Keywords: Depressive disorder, major; Treatment-resistant depression; Burden; Review; AD; Antidepressant; CBT; Cognitive behavioral therapy; CT; cognitive therapy; ECT; Electroconvulsive therapy; EQ-5D; EuroQol Five Dimension; HAM-D; Hamilton Depression Rating Scal
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: EC50; concentration of a drug which induces a response halfway between the baseline and maximum after a specified exposure time; LOEC; lowest observed effect concentration; NOEC; no observed effect concentration; OECD; Organisation for Economic Co-operati
Keywords: BP; blood pressure; CI; confidence interval; CPT-4; Current Procedural Terminology, 4th Edition; HIPAA; Health Insurance Portability and Accountability Act; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; IOP; intr
Keywords: drug-drug interactions; psychiatric disorders; psychopharmacology; ASA; aspirin; BDI; Beck Depression Inventory; BZD; benzodiazepine; CAD; coronary artery disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; CYP; cytochro
Keywords: AE; adverse event; AER; adverse event rate; CAM; complementary and alternative medicine; CCMD; Chinese classification of mental disorders; CI; confidence interval; CPG; clinical practice guideline; DSM; diagnostic and statistical manual of mental disorder
Keywords: MDD; Major Depressive Disorder; SSRI; Selective Serotonin Reuptake Inhibitor; SNRI; Serotonin Norepinephrine Reuptake Inhibitor; NRI; Norepinephrine Reuptake Inhibitor; rTMS; Repetitive Transcranial Magnetic Stimulation; Antidepressant response; Cognition
Keywords: ATS; amphetamine-type stimulants; CNS; central nervous system; DFC; drug-facilitated crime; DFSA; drug-facilitated sexual assault; GABA; gamma aminobutyric acid; GHB; gamma hydroxybutyric acid; GBL; gamma butyrolactone; MDA; 3,4-methylenedioxyamphetamine;
Keywords: AUD; Alcohol use disorder; FDA; Food and Drug Administration; MOR; Mu opioid receptor; DOR; Delta opioid receptor; KOR; Kappa opioid receptor; NMDA; N-methyl-d-aspartate; GABA; Gaba amino butyric acid; DSM-IV; Diagnostic and statistical measurement IV; PA
Keywords: Venlafaxine; Withdrawal; Neonate; Abstinence; Discontinuation; Encephalopathy; SNRI; serotonin-noradrenergic reuptake inhibitor; SSRI; serotonin-selective reuptake inhibitor; EEG; Electroencephalogram;
Keywords: MÏs; macrophages; MAO-A; monoamine oxidase-A; SNRI; serotonin-norepinephrine re-uptake inhibitors; SSRI; selective serotonin re-uptake inhibitors; TCA; tricyclic antidepressant drugs; Antidepressant drugs; Immune regulation; Immune suppression; Macrophag
Keywords: ANS; autonomic nervous system; BMI; body mass index; BP; blood pressure; CVD; cardiovascular disease; ECG; electrocardiogram; HR; heart rate; HRV; heart rate variability; IAT; implicit association task; IBI; interbeat interval; ICG; impedance cardiography
Keywords: AE; adverse event; CDSR; Cochrane Database of Systematic Reviews; COMTI; catechol-O-methyltransferase inhibitor; DOPA; dopamine; FDA; Food and Drug Administration; GABA; γ-aminobutyric acid; GnRH; gonadotropin-releasing hormone; IQR; interquartile range;
Keywords: chronic pain; narrative review; neuropathic pain; SNRI; venlafaxine;
Keywords: ADD; antidepressant drug; ADHD; attention deficit hyperactivity disorder; ASD; autism spectrum disorders; BSID; Bayley scales of infant and toddler development instrument; HR; hazards ratio; MDD; major depressive disorder; OR; odds ratio; SNRI; serotonin
Keywords: Narcolepsy; Cataplexy; Orexin; Hypocretin; Neurodegeneration; Animal models; 5-HT; 5-hydroxytrytamine (serotonin); α1; noradrenergic alpha 1 receptor; α2; noradrenergic alpha 2 receptor; ACh; acetylcholine; Atax; orexin/ataxin-3 transgenic; BAC; bacteri
Keywords: 5-HIAA; 5-hydroxyindoleacetic acid, main 5-HT metabolite; 5-HT; 5-hydroxytryptamine, serotonin; EF; executive functioning; G Ã E; Gene Ã Environment (interactions); HPA; hypothalamic-pituitary-adrenal; MAO; monoamine oxidase; SERT; 5-HT transporte
Keywords: HDAC; histone deacetylase; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin noradrenaline reuptake inhibitor; BDNF; Brain-derived neurotrophic factor; GDNF; glial cell line-derived neurotrophic factor; FEGF; vascular endothelial growth factor
Keywords: ALA; alpha-lipoic acid; CAT; catalase; CORT; corticosterone; DVS; desvenlafaxine; GSH; reduced glutathione; HC; hippocampus; LP; lipid peroxidation; MDA; malondialdehyde; MDD; major depressive disorder; PMD; psychotic major depression; PFC; prefrontal cor
Keywords: Duloxetine; Seizures; SNRI; Antidepressant; Anticonvulsant; Oxidative stressCS, convulsive seizures; PTZ, pentylenetetrazol; SSRIs, selective serotonin reuptake inhibitors; SNRIs, serotonin and norepinephrine reuptake inhibitors; EEG, electroencephalogram
Keywords: CBT; cognitive behavioral therapy; CYP2D6; cytochrome P450 2D6; DHEA; dehydroepiandrosterone; FDA; Food and Drug Administration; GSM; genitourinary syndrome of menopause; MPA; medroxyprogesterone acetate; SERM; selective estrogen receptor modulator; SGB;
Keywords: DD; defecatory disorder; GI; gastrointestinal; 5-HT; 5-hydroxytryptamine; IBS; irritable bowel syndrome; NBS; narcotic bowel syndrome; OBD; opioid bowel dysfunction; OIC; opioid-induced constipation; SNRI; serotonin and norepinephrine reuptake inhibitor;
Keywords: ACC; anterior cingulate cortex; CBT; cognitive-behavioral therapy; GAD; generalized anxiety disorder; MPR; multidisciplinary pain rehabilitation; PD; personality disorder; PFC; prefrontal cortex; PTSD; posttraumatic stress disorder; SNRI; serotonin-norepi
Keywords: ACTH; adrenocorticotropic hormone; ADH; alcohol dehydrogenase; AUD; alcohol use disorder; CBI; cognitive behavioral interventions; CeA; central nucleus of the amygdala; CRF; corticotropin releasing factor; CRFr; CRF receptor; DSM-5; Diagnostic and Statist
Keywords: SNRI; Monoamine; Reserpine; Pain; Depression; Descending pain modulatory system;
Keywords: Insomnia; Traumatic brain injury; Concussion; Delayed recovery; Rehabilitation; Diagnostic modeling; DSM-IV-TR; Diagnostic and Statistical Manual of Mental Disorders, 4th Edition - Text Revision; HADS-A; Hospital Anxiety and Depression Scale - Anxiety
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; AUC; area under the curve; BMI; body mass index; BP; blood pressure; BUN; blood urea nitrogen; CI; confidence intervals; Cmax; maximum concentration; CNS; central nervous system; EIA; enzyme
Keywords: selective serotonin reuptake inhibitor; SSRI; selective norepinephrine reuptake inhibitor; SNRI; depression; risk; pregnancy;
Keywords: Anti-depressant; SSRI; SNRI; TCA; Cancer; Risk factor;
Keywords: levomilnacipran; major depressive disorder; pharmacokinetics; SNRI; transporter inhibition;
Keywords: CHEP; contact heat-evoked potential; CNS; central nervous system; CPRS; complex regional pain syndrome; LEP; laser-evoked potential; NMDA; N-methyl-d-aspartate; NNT; number needed to treat; QSART; quantitative sudomotor axon reflex test; RCT; randomized
Keywords: Menopause; Vasomotor symptoms; Estrogen; Progestogen; SSRI; SNRI;
Keywords: 5-HT; 5-hydroxytryptamine, serotonin; CRF; corticotropin-releasing factor; HPA; hypothalamus-pituitary-adrenal; WHO; World Health Organization; DSM-5; Diagnostic and Statistical Manual of Mental Disorders 5; MOA; monoamine oxidase; VMAT; vesicular monoami
Keywords: Multiple sclerosis; Restless legs syndrome; Polysomnography; Periodic leg movements; International Restless Legs Syndrome Study Group questionnaire; AASM; American Academy of Sleep Medicine; AHI; apnea-hypopnea index; CI; confidence interval; EDSS; Expa
Keywords: Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: ICD-9; International Classification of Diseases, Ninth Revision; MIMIC; Multiparameter Intelligent Monitoring in Intensive Care; RCT; randomized controlled trial; SAPS; Simplified Acute Physiology Score; SNRI; serotonin norepinephrine reuptake inhibitor;
Keywords: Duloxetine; Antidepressant; SNRI; Serotonin toxicity; Adverse drug reaction; Sudden death;
Keywords: OCT2; organic cation transporter 2; hOCT2; human organic cation transporter 2; MDCK; Madin-Darby canine kidney; TCA; tricyclic antidepressant; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin-norepinephrine reuptake inhibitor; MAOI; monoa
Keywords: Chronic pain; Fibromyalgia; SNRI; fMRI; Functional connectivity5-HT, serotonin; ACC, anterior cingulate cortex; BPI, brief pain inventory; CNS, central nervous system; DMN, default mode network; DLPFC, dorsolateral prefrontal cortex; fMRI, functional magn
Keywords: MDD; major depressive disorder; PIC; proinflammatory cytokine; AIC; anti-inflammatory cytokine; HC; hippocampus; LTP; long term potentiation; HPA; hypothalamus-pituitary-adrenal; 3-HK; 3-hydroxykynurenine; QA; quinolinic acid; IDO; indoleamine-2,3-dioxyge
Keywords: ACTH; Adrenocorticotropic hormone; ANOVA; Analysis of variance; ANS; Autonomic nervous system; CgA; Chromogranin A; Dex/CRH; Combined dexamethasone suppression/corticotropin releasing hormone stimulation test; DSM-IV; Diagnostic and Statistical Manual of
Keywords: IL-6; interleukin-6; TNF-α; tumor necrosis factor- alpha; BMI; body mass index; MDD; major depressive disorder; MDD-M; major depressive disorder with melancholic features; MDD-A; major depressive disorder with atypical features; IL-1β; Interleukin-1be
Keywords: Antidepressant; Low/high activity; SSRI; SNRI; Rat; Estrous cycle;
Keywords: PMDD; premenstrual dysphoric disorder; PWD; progesterone withdrawal; FST; forced swim test; 5-HT; serotonin; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin norepinephrine reuptake inhibitor; SERT; serotonin transporter; AMI; amitriptyline;
Keywords: ACh; acetylcholine; ADHD; attention deficit hyperactivity disorder; ANOVA; analysis of variance; BSA; bovine serum albumin; CNS; central nervous system; DA; dopamine; dr; dose ratio; FDA; United States Food and Drug Administration; nAChR; nicotinic acetyl
Keywords: mPFC; medial prefrontal cortex; ACC; anterior cingulate cortex; DG; dentate gyrus; NAc; nucleus accumbens; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor; NMDAR; N-methyl-d-aspartic acid receptor; VDCC; voltage-dependent calcium ch
Keywords: 5-HT; serotonin; 5-HTP; 5-hydroxy-l-tryptophan; 5-HTT; 5-HT transporter; MAO; monoamine oxidase; MAOA-I; monoamine oxidase type A inhibitor; MAOB-I; monoamine oxidase type A inhibitor; MAOA/B-I; monoamine oxidase type A/B inhibitor; SNRI; serotonin/norepi
Les hyponatrémies sous ISRS/IRSNA : étude épidémiologique descriptive et comparative des taux d'incidence de cas notifiés à partir des données de la Banque nationale de pharmacovigilance et de l'Assurance maladie
Keywords: Hyponatrémie; ISRS; IRSNA; Ãtude pharmacoépidémiologique; Hyponatremia; SSRI; SNRI; Pharmacoepidemiological study;
Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population
Keywords: SF-IGB; SNRI; SSRI; Overweight; Bariatric Surgery; Obesity; Balloon; Endoscopy; BMI; body mass index; FDA; Food and Drug Administration; OIB; Orbera intragastric balloon; SNRI; serotonin-norepinephrine re-uptake inhibitor; SSRI; selective serotonin re-
Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies
Keywords: Ketamine; microRNA; Prefrontal cortex; Small interfering RNA; RNA interference; 5-HT; serotonin; 5-HT1A receptor; serotonin 1A receptor; A1; adenosine A1 receptor; AchE; acetylcholinesterase; AGO; argonaute; Akt-mTOR; protein kinase B/Akt- mammalian targe
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of GutâBrain Interaction): A Rome Foundation Working Team Report
Keywords: Functional Gastrointestinal Disorders; Central Neuromodulators; Antidepressants; Antipsychotics; Disorders of Gut Brain Interaction; Chronic Abdominal Pain; CBT; cognitive behavioral therapy; CNS; central nervous system; CVS; cyclic vomiting syndrome; D2;